Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2025 Earnings Call Transcript
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2025 Earnings Call Transcript May 14, 2025Oncolytics Biotech Inc. beats earnings expectations.
Posts Tagged ‘NASDAQ:ONCY’
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2024 Earnings Call Transcript
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2024 Earnings Call Transcript March 7, 2025Oncolytics Biotech Inc. beats earnings expectations.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to Oncolytics Biotech's Third Quarter 2024 Conference Call. All participants are in a listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2024 Earnings Call Transcript
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2024 Earnings Call Transcript August 1, 2024Oncolytics Biotech Inc. beats earnings expectations.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2024 Earnings Call Transcript
Operator: Good afternoon and welcome to Oncolytics Biotech's First Quarter 2024 Conference Call. [Operator Instructions].
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q3 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Oncolytics Biotech's Third Quarter 2023 Conference Call. All participants are now in listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Oncolytics Biotech's Second Quarter 2023 Conference Call. All participants are now in listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q1 2023 Earnings Call Transcript
Operator: Good morning. And welcome to Oncolytics Biotech's First Quarter 2023 Conference Call. All participants are now in listen-only mode.
Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2022 Earnings Call Transcript
Operator: Welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2022 Conference Call. Please be advised that this call is being recorded at the company's request.
Is Oncolytics Biotech, Inc. (ONCY) A Good Stock To Buy?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Progenics Pharmaceuticals, Inc. (PGNX): Insiders Aren’t Crazy About It But Hedge Funds Love It
To the average investor, there are tons of indicators shareholders can use to watch publicly traded companies.
Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)
At the moment, there are tons of methods market participants can use to watch Mr. Market. A pair of the most useful are hedge fund and insider trading sentiment.
Is Coronado Biosciences Inc (CNDO) Going to Burn These Hedge Funds?
If you'd ask most market participants, hedge funds are viewed as worthless, old financial vehicles of years past.
Should You Avoid GTx, Inc. (GTXI)?
Is GTx, Inc. (NASDAQ:GTXI) a superb investment right now? Investors who are in the know are taking a pessimistic view.
Oncolytics Biotech, Inc. (USA) (ONCY): This High-Risk, High-Reward Biotech Is Worth a Look
Let me preface this by saying that investing in the biotech sector can sometimes be nothing more than speculating.
This Metric Says You Are Smart to Buy Curis, Inc. (CRIS)
Curis, Inc. (NASDAQ:CRIS) was in 10 hedge funds' portfolio at the end of March. CRIS investors should be aware of an increase in hedge fund interest in recent months.
Oncolytics Biotech, Inc. (USA) (ONCY): This Promising Biotech Can Triple
Cancer is one of the deadliest challenges that humans face today. Different forms of cancer have taken millions of lives all around the world.
Should You Buy Progenics Pharmaceuticals, Inc. (PGNX)?
Is Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) a worthy investment now? Prominent investors are taking an optimistic view.
Galena Biopharma Inc (GALE), Oncolytics Biotech, Inc. (USA) (ONCY): 2 Drugs With Acquisition Potential
Big pharmaceutical players, known as Big Pharma, depend on patents to fend of generic threats to their blockbuster drugs.
Amgen, Inc. (AMGN), Bristol Myers Squibb Co. (BMY): Can Financial Innovation Unlock a Cure for Cancer?
A few years ago, Andrew W. Lo from the MIT Sloan School of Management gave a lengthy talk at a meet-and-greet for prospective students of the Master of Finance program.
2 Biopharmaceuticals With Huge Upside Potential: Galena Biopharma Inc (GALE), Oncolytics Biotech, Inc. (USA) (ONCY)
The Biopharmaceutical industry has been one of the most profitable industries last year.
3 Potential Game-Changing Cancer Drugs: Amgen, Inc. (AMGN), Merck & Co., Inc. (MRK), ZIOPHARM Oncology Inc. (ZIOP)
Cancer just might be one of the scariest words in the English language. What goes through your mind when you hear that someone close to you has cancer? Sadness, probably.
3 Horrendous Health-Care Stocks This Week: Humana Inc. (HUM) and More
It's been a wet week for much of the U.S.
Oncolytics Biotech, Inc. (USA) (ONCY): Huge Upside Potential Despite Recent Rallies
Shares of Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) have risen by more than 35% since last Thursday.
Whoa! What Just Happened to My Stock? MannKind Corporation (MNKD), Zynga Inc (ZNGA)
The Dow Jones Industrial Average ended last week on a high note, closing up almost 50 points, but that put it at about the same spot where it ended the week before, though slightly...
Are These Moves Higher Well-Deserved? Zynga Inc (ZNGA), Oncolytics Biotech, Inc. (ONCY) and More
On Friday, we saw an unusual amount of volatility in many stocks during a day of slight gains for the broader market.
This Week in Biotech: Celgene Corporation (CELG) Biogen Idec Inc. (BIIB)
With the SPDR S&P Biotech Index up 21% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
3 Humongous Health-Care Stocks This Week: Dendreon Corporation (DNDN), Neurocrine Biosciences, Inc. (NBIX)
As millions of Americans brace themselves for a massive blizzard, a handful of health-care stocks have been heating up the charts over the past few days.
